← Back to Vaccine Database

AAV5-RBD-S vaccine (BCD-250)

Viral vector (Non-replicating) vaccine · VDDBV0025

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05037188 Phase 2COVID-19